Delivery Order SPE2DB20D3101-SPE2DB24FRMK1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract, valued at $2,190.18, is a delivery order for the supply of Phenobarbital 130 mg/ml vials. The contract has a firm fixed price pricing type and an ultimate completion date of May 20, 2025. This award is not associated with a set-aside program and appears to be part of a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,065.20 firm-fixed-price delivery order is for the supply of Phenobarbital 130 mg/mL solution, a critical medication, to support federal healthcare programs and military treatment facilities. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,630.72 firm fixed-price delivery order is for the supply of Phenobarbital 65 mg/ml vial. The award has an ultimate completion date of March 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, valued at $2,320.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Phenobarbital 130 mg/ml vials, a medication used for various medical conditions. The contract does not have a set-aside designation, indicating it was open to general competition. It is a Firm Fixed Price Delivery Order with an ultimate completion date of April 19, 2023. Amerisourcebergen also...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,938.32 fixed-price delivery order is for the supply of Phenobarbital 130 mg/mL vials. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,855.42 firm fixed-price delivery order is for the supply of Phenobarbital 65 mg/mL vials, a medical product used in various healthcare settings. The contract has an ultimate completion date of January 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,172.43, is for the delivery of PHENOBARBITAL 130 MG/ML VIALML to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award, valued at $5,892.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a completion date of January 7, 2025, is for the delivery of Phenobarbital 130 mg/ml vials. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award, valued at $1,292.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564675568 – PHENOBARBITAL 130 MG/ML VIALML, with a performance period ending on May 22, 2024. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award, valued at $5,680.85, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563075665 Phenobarbital 130 mg/ml vial, a medical product used in various healthcare settings. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRMK1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,873.98 firm fixed-price delivery order is for the supply of 130 mg/ml vials of the medication Phenobarbital. The contract has a June 2024 award date and a June 2024 ultimate completion date. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not indicate any set-aside requirements, suggesting open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 6/10/24 |